Specialist Clinic Models and Service Provision
The paper’s treatment chapters (Part III — Treatment and Management) document what treatments exist for ME/CFS and what evidence supports them. This section addresses a different question: who delivers that care, in what setting, and is the clinical model designed for the disease?
Specialist ME/CFS clinical centers — the Bateman Horne Center (Salt Lake City), the Stanford ME/CFS Clinic, the Open Medicine Institute (OMI/Mountain View), the Hadassah ME/CFS Center (Jerusalem), the Charité Fatigue Center (Berlin), and others — are widely cited as models for care delivery. The U.S. ME/CFS Clinician Coalition consensus statement describes what specialist clinicians recommend (Bateman et al. 2021), and patient advocacy groups routinely call for expanded specialist clinic access.
The uncomfortable question is: does specialist clinic care produce better outcomes than well-informed primary care? The answer is unknown. Zero RCTs or controlled comparisons exist. No study has compared diagnostic accuracy, time-to-diagnosis, functional outcomes, or patient satisfaction between specialist clinics and primary care. The recommendation for specialist care rests on expert consensus and patient preference — not on demonstrated superiority.
This is not an argument against specialist clinics. It is an argument for evaluating them. A disease affecting millions, with diagnostic delays measured in years and a treatment evidence base rated low-to-moderate, should know whether the care model recommended by experts actually delivers better results than the model most patients receive. (Certainty: N/A — this is a research-gap identification, not a factual claim.)
Consequence: Until specialist clinic models are evaluated, health systems have no evidence basis for deciding whether to invest in them. The current situation — where specialist clinics exist in a handful of wealthy cities and most patients receive no specialist care at all — may be the worst of both worlds: the clinics’ existence creates an implicit standard of care that few patients can access, without evidence that the standard produces better outcomes. Severity applicability: specialist clinic access is most critical for severe/very severe patients who cannot be managed in primary care alone, but the evidence gap affects all severity levels equally.
0.1 A Concrete Care-Delivery Example: the Bateman Horne Center Operational Model
As real-world contrast to the unevaluated-specialist-clinic question above, the Bateman Horne Center (BHC, Salt Lake City) — which describes itself as a U.S. ME/CFS Center of Excellence (a self-designation; no independent comparative data rank specialist centers) — operationalizes specialist care through a specific care-delivery architecture. Its components are descriptive and as self-reported on the center’s website (batemanhornecenter.org, accessed 2026-07-23), not independently verified, and, as with all specialist-clinic models, carry zero comparative-effectiveness evidence (see Do Specialist Clinics Improve Outcomes?): the membership-based clinic model pairs a comprehensive initial assessment with a PCP-maintenance requirement, formalizing the specialist-vs-primary-care division of labor; the center’s explicit opioid policy declines to manage chronic daily opioids — a policy with both a patient-safety rationale and access-to-pain-relief critics, unevaluated in ME/CFS; its EMR is customized with ME/CFS-specific fields (Good Day/Bad Day status, head-up-angle tracking); and it runs a Project ECHO-style provider-education effort to spread specialist knowledge to community clinicians. These are presented not as a validated template for reform but as a concrete, documented example of what a specialist ME/CFS care-delivery structure looks like — the descriptive detail the broader specialist-clinic question leaves unaddressed. Two cautions require emphasis: (1) the membership fee and required ongoing PCP relationship are themselves potential access barriers for a patient population with documented poverty, primary-care invalidation, and provider-search fatigue — whether this structure filters out the most disadvantaged or most severe patients is unstudied; (2) a clinic-based model serves the severity range able to attend a clinic, and home-bound severe/very-severe care falls outside the documented model. (Certainty: N/A — descriptive care-model documentation, not a causal or comparative claim. Severity applicability: the model serves patients able to attend a clinic; home-bound severe/very-severe care is outside the documented model.)
Consequence: This example gives health-system planners and advocates a documented illustration of how one specialist center structures membership, PCP coordination, opioid policy, EMR fields, and provider education — a concrete descriptive example only, not a reference standard, and providing no evidence that this structure improves outcomes over usual care. (Origin: /integrate-topic bhc-clinical-operations-model — B-gate exploratory; BHC website source accessed 2026-07-23.)
1 Pediatric Health Services
Children and adolescents with ME/CFS face distinct challenges that adult-oriented services often do not address.
A meta-ethnography of qualitative studies on children’s experiences of ME/CFS identified profound biographical disruption — the disease disrupts education, social development, and family relationships — and documented the critical importance of communication between healthcare providers and schools (Parslow, Harris, et al. 2017). Health professionals identified four domains for pediatric assessment: physical function, emotional well-being, social participation, and educational engagement. No validated child-specific patient-reported outcome measures (PROMs) exist for pediatric ME/CFS (Parslow, Shaw, et al. 2017). (Certainty: 0.60–0.65 — rigorous qualitative synthesis; moderate sample sizes; 2017 studies, pre-COVID pediatric surge. Severity coverage: qualitative samples likely overrepresent less severely affected children who can participate in research.)
Consequence: A child diagnosed with ME/CFS enters a healthcare system that has not designed its services, its outcomes measures, or its school liaison protocols for the disease. The result is predictable: educational disruption compounding medical disability. The pediatric-to-adult transition — already difficult in chronic disease — has no studied model for ME/CFS.